Biotechnology · Healthcare
Board Member
2023-01-01–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Compass Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CMPX alertsRichard S. Lindahl is recorded as Board Member at Compass Therapeutics, Inc. (CMPX) since January 1, 2023. The newest filing on record that lists Richard S. Lindahl as Board Member at Compass Therapeutics, Inc. (CMPX) is dated April 29, 2026. Compass Therapeutics, Inc. reported in an 8-K filed April 24, 2023 that Richard S. Lindahl was appointed member and chairman of the Company's Audit Committee, effective April 21, 2023. Compass Therapeutics, Inc. reported in an 8-K filed April 24, 2023 that Richard S. Lindahl was appointed Class III director, effective April 21, 2023. Compass Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Compass Therapeutics, Inc. includes Thomas J. Schuetz (CEO and Board Member), Thomas Schuetz (CEO and Board Member), Thomas Schuetz, MD, PhD (CEO and Chairman) and 7 others.
“Mr. Lindahl was also appointed to serve as a member and chairman of the Company's Audit Committee.”
“appointed Mr. Lindahl as a Class III director, effective immediately to fill a vacant Class III Board seat, with a term expiring at the Company's annual meeting of stockholders in 2023.”
2023-04-21–present
2023-01-01–present
Last confirmed April 29, 2026
Biotechnology · Healthcare
Board Member
2023-01-01–present